Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

The impact of active surveillance and health education on an Ebola virus disease cluster — Kono District, Sierra Leone, 2014–2015

Authors: Tasha Stehling-Ariza, Alexander Rosewell, Sahr A. Moiba, Brima Berthalomew Yorpie, Kai David Ndomaina, Kai Samuel Jimissa, Eva Leidman, Dingeman J. Rijken, Colin Basler, James Wood, Dumbuya Manso

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

During December 2014–February 2015, an Ebola outbreak in a village in Kono district, Sierra Leone, began following unsafe funeral practices after the death of a person later confirmed to be infected with Ebola virus. In response, disease surveillance officers and community health workers, in collaboration with local leadership and international partners, conducted 1 day of active surveillance and health education for all households in the village followed by ongoing outreach. This study investigated the impact of these interventions on the outbreak.

Methods

Fifty confirmed Ebola cases were identified in the village between December 1, 2014 and February 28, 2015. Data from case investigations, treatment facility and laboratory records were analyzed to characterize the outbreak. The reproduction number (R) was estimated by fitting to the observed distribution of secondary cases. The impact of the active surveillance and health education was evaluated by comparing two outcomes before and after the day of the interventions: 1) the number of days from symptom onset to case-patient isolation or death and 2) a reported epidemiologic link to a prior Ebola case.

Results

The case fatality ratio among the 50 confirmed Ebola cases was 64.0 %. Twenty-three cases occurred among females (46.0 %); the mean age was 39 years (median: 37 years; range: 5 months to 75 years). Forty-three (87.8 %) cases were linked to the index case; 30 (61.2 %) were either at the funeral of Patient 1 or had contact with him while he was ill. R was 0.93 (95 % CI: 0.15–2.3); excluding the funeral, R was 0.29 (95 % CI: 0.11–0.53). The mean number of days in the community after onset of Ebola symptoms decreased from 4.0 days (median: 3 days; 95 % CI: 3.2–4.7) before the interventions to 2.9 days (median: 2 days; 95 % CI: 1.6–4.3) afterward. An epidemiologic link was reported in 47.6 % of case investigations prior to and 100 % after the interventions.

Conclusions

Initial case investigation and contact tracing were hindered by delayed reporting and under-reporting of symptomatic individuals from the community. Active surveillance and health education contributed to quicker identification of suspected cases, interrupting further transmission.
Literature
1.
go back to reference Dixon MG, Schafer IJ. Ebola viral disease outbreak—West Africa, 2014. MMWR Morb Mortal Wkly Rep. 2014;63:548–51.PubMed Dixon MG, Schafer IJ. Ebola viral disease outbreak—West Africa, 2014. MMWR Morb Mortal Wkly Rep. 2014;63:548–51.PubMed
4.
go back to reference Christie A, Davies-Wayne GJ, Cordier-Lasalle T, Blackley DJ, Laney AS, Williams DE, et al. Possible sexual transmission of Ebola virus — Liberia, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:479–81.PubMed Christie A, Davies-Wayne GJ, Cordier-Lasalle T, Blackley DJ, Laney AS, Williams DE, et al. Possible sexual transmission of Ebola virus — Liberia, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:479–81.PubMed
5.
go back to reference Bower H, Johnson S, Bangura MS, Kamara AJ, Kamara O, Mansaray SH, et al. Exposure-specific and agespecific attack rates for Ebola virus disease in Ebola-affected households, Sierra Leone. Emerg Infect Dis. 2016;22:1403–11. Bower H, Johnson S, Bangura MS, Kamara AJ, Kamara O, Mansaray SH, et al. Exposure-specific and agespecific attack rates for Ebola virus disease in Ebola-affected households, Sierra Leone. Emerg Infect Dis. 2016;22:1403–11.
7.
go back to reference Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438:355–9.CrossRefPubMed Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438:355–9.CrossRefPubMed
8.
go back to reference Lindblade KA, Kateh F, Nagbe TK, Neatherlin JC, Pillai SK, Attfield KR, et al. Decreased Ebola transmission after rapid response to outbreaks in remote areas, Liberia, 2014. Emerg Infect Dis. 2015;21:1800–7.CrossRefPubMedPubMedCentral Lindblade KA, Kateh F, Nagbe TK, Neatherlin JC, Pillai SK, Attfield KR, et al. Decreased Ebola transmission after rapid response to outbreaks in remote areas, Liberia, 2014. Emerg Infect Dis. 2015;21:1800–7.CrossRefPubMedPubMedCentral
10.
go back to reference Fitzpatrick G, Vogt F, Moi Gbabai O, Black B, Santantonio M, Folkesson E, et al. Describing readmissions to an Ebola case management centre (CMC), Sierra Leone, 2014. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2014;19:20924. Fitzpatrick G, Vogt F, Moi Gbabai O, Black B, Santantonio M, Folkesson E, et al. Describing readmissions to an Ebola case management centre (CMC), Sierra Leone, 2014. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2014;19:20924.
12.
go back to reference Pittalis S, Fusco FM, Lanini S, Nisii C, Puro V, Lauria FN, et al. Case definition for Ebola and Marburg haemorrhagic fevers: a complex challenge for epidemiologists and clinicians. New Microbiol. 2009;32:359–67.PubMed Pittalis S, Fusco FM, Lanini S, Nisii C, Puro V, Lauria FN, et al. Case definition for Ebola and Marburg haemorrhagic fevers: a complex challenge for epidemiologists and clinicians. New Microbiol. 2009;32:359–67.PubMed
Metadata
Title
The impact of active surveillance and health education on an Ebola virus disease cluster — Kono District, Sierra Leone, 2014–2015
Authors
Tasha Stehling-Ariza
Alexander Rosewell
Sahr A. Moiba
Brima Berthalomew Yorpie
Kai David Ndomaina
Kai Samuel Jimissa
Eva Leidman
Dingeman J. Rijken
Colin Basler
James Wood
Dumbuya Manso
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1941-0

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine